GV 2017 GP, L.L.C.
Insider CIK 1733338 · GTLB 10% owner · DBTX 10% owner · RCUS 10% owner · LIFE 10% owner · VERV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LIFE Ethos Technologies Inc. | C Conversion deriv | 2026-01-30 | 2026-01-30 | 3,287,925 | — | $0 | 0 | SEC↗ |
| LIFE Ethos Technologies Inc. | C Conversion deriv | 2026-01-30 | 2026-01-30 | 552,126 | — | $0 | 0 | SEC↗ |
| LIFE Ethos Technologies Inc. | C Conversion deriv | 2026-01-30 | 2026-01-30 | 1,751,791 | — | $0 | 0 | SEC↗ |
| LIFE Ethos Technologies Inc. | C Conversion | 2026-01-30 | 2026-01-30 | 1,755,632 | — | $0 | 1,755,632 | SEC↗ |
| LIFE Ethos Technologies Inc. | S Sale | 2026-01-30 | 2026-01-30 | 89,676 | $19.00 | $1.70M | 3,198,249 | SEC↗ |
| LIFE Ethos Technologies Inc. | S Sale | 2026-01-30 | 2026-01-30 | 1,755,632 | $19.00 | $33.36M | 0 | SEC↗ |
| LIFE Ethos Technologies Inc. | C Conversion | 2026-01-30 | 2026-01-30 | 571,907 | — | $0 | 571,907 | SEC↗ |
| LIFE Ethos Technologies Inc. | C Conversion | 2026-01-30 | 2026-01-30 | 3,287,925 | — | $0 | 3,287,925 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 1,800,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 4,260,047 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 6,108,442 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 651 | $31.99 | $20.8K | 242 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 243 | $32.90 | $8.0K | 4,260,047 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 650 | $31.99 | $20.8K | 4,260,290 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 47,690 | $31.12 | $1.48M | 893 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 242 | $32.90 | $8.0K | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-04 | 2022-11-08 | 48,583 | — | $0 | 6,108,442 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 47,690 | $31.12 | $1.48M | 4,260,940 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 22,279 | $32.32 | $720.1K | 4,335,919 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 1,755 | $33.84 | $59.4K | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 25,535 | $33.14 | $846.2K | 1,755 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 22,279 | $32.32 | $720.1K | 27,290 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-03 | 2022-11-04 | 49,569 | — | $0 | 6,157,025 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 25,534 | $33.14 | $846.2K | 4,310,385 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 1,755 | $33.84 | $59.4K | 4,308,630 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 8,930 | $36.78 | $328.4K | 4,358,198 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 10,372 | $36.28 | $376.3K | 4,367,128 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 9,350 | $34.78 | $325.2K | 4,377,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 8,930 | $36.78 | $328.4K | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 10,372 | $36.28 | $376.3K | 8,930 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 9,349 | $34.78 | $325.2K | 19,302 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-02 | 2022-11-04 | 28,651 | — | $0 | 6,206,594 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 29,326 | $36.69 | $1.08M | 4,389,487 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 260 | $38.64 | $10.0K | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 2,377 | $37.82 | $89.9K | 260 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 29,326 | $36.69 | $1.08M | 2,637 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-01 | 2022-11-02 | 31,963 | — | $0 | 6,235,245 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 2,377 | $37.82 | $89.9K | 4,387,110 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 260 | $38.64 | $10.0K | 4,386,850 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 88 | $40.64 | $3.6K | 4,418,813 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 6,601 | $40.16 | $265.1K | 4,418,901 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 23,275 | $38.94 | $906.3K | 4,425,502 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 23,732 | $37.91 | $899.7K | 4,448,777 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 88 | $40.64 | $3.6K | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 6,601 | $40.16 | $265.1K | 88 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 23,276 | $38.94 | $906.4K | 6,689 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 23,732 | $37.91 | $899.7K | 29,965 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-10-31 | 2022-11-02 | 53,697 | — | $0 | 6,267,208 | SEC↗ |
| GTLB Gitlab Inc. | C Conversion deriv | 2021-10-18 | 2022-05-06 | 8,374,040 | — | $0 | 0 | SEC↗ |
| GTLB Gitlab Inc. | C Conversion deriv | 2021-10-18 | 2022-05-06 | 514,736 | — | $0 | 0 | SEC↗ |
| GTLB Gitlab Inc. | C Conversion deriv | 2021-10-18 | 2022-05-06 | 8,888,776 | — | $0 | 8,888,776 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 58,528,428 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 6,320,905 | — | $0 | 6,320,905 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-17 | 6,250,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-17 | 494,649 | — | $0 | 494,649 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 1,924,474 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion | 2018-03-19 | 2018-03-19 | 1,924,474 | — | $0 | 1,924,474 | SEC↗ |